3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
21
Other hematologic neoplasm
10
Plasma cell
4
Myeloid
4
Genitourinary
4
Dermatologic
2
Thoracic
1
Sarcoma
1
Other neoplasm
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Breast Neoplasms
9481
Triple Negative Breast Neoplasms
635
Neoplasms
413
Lung Neoplasms
342
Prostatic Neoplasms
321
Ovarian Neoplasms
299
Colorectal Neoplasms
289
Neoplasm Metastasis
280
Motor Activity
267
Carcinoma, Intraductal, Noninfiltrating
231
Colonic Neoplasms
193
Breast Neoplasms, Male
172
Lymphedema
170
Melanoma
158
Pancreatic Neoplasms
152
Breast Carcinoma In Situ
151
Carcinoma, Non-Small-Cell Lung
149
Uterine Cervical Neoplasms
144
Fatigue
140
Head and Neck Neoplasms
132
Pain
122
Breast Cancer Female
122
Brain Neoplasms
118
Stomach Neoplasms
117
Sarcoma
106
Depression
105
Breast Cancer Lymphedema
101
Anxiety Disorders
101
Lymphoma
96
Cardiotoxicity
89
Interventions
palbociclib
1
Rivaroxaban
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Immune System Diseases
×
Breast
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled